Jumping directly to 10 mg would likely cause severe gastrointestinal side effects and is not recommended under any circumstances
What does this mean for you practically
Current FDA indications are limited to diabetes and obesity, and any addiction-related use would be off-label
References consulted in writing this post: Alexandra M Bodnaruc 1, Denis Prudhomme 2, Rosanne Blanchet 3, Isabelle Giroux 4 Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
Our White Plains medical team helps you move at a pace that is both safe and effective, without extreme restriction or constant fatigue
Its administration is typically via subcutaneous injection once weekly, and dosing in clinical trials has ranged from 0.5 mg to 12 mg, adjusted to optimize efficacy and tolerability